General Information of the Compound
Compound ID
CP0152345
Compound Name
2-[4-[(3Z)-3-(2-chloranylthioxanthen-9-ylidene)propyl]piperazin-1-yl]ethanol;hydrochloride
    Show/Hide
Synonyms
(Z)-4-(3-(2-Chlorothioxanthen-9-ylidene)propyl)-1-piperazineethanol
2-[4-[(3Z)-3-(2-chlorothioxanthen-9-ylidene)propyl]piperazin-1-yl]ethanol
2-{4-[(3Z)-3-(2-chloro-10H-dibenzo[b,e]thiopyran-10-ylidene)propyl]piperazin-1-yl}ethanol
2-{4-[3-(2-chloro-10H-dibenzo[b,e]thiopyran-10-ylidene)propyl]piperazin-1-yl}ethanol
4-(3-(2-Chlorothioxanthen-9-ylidene)propyl)-1-piperazineethanol
Acuphase
Acuphase (TN)
Alpha Clopenthixol
Alpha-Clopenthixol
CLOPENTHIXOL
Cisordinol
Cisordinol (TN)
Clopenthixol (USAN)
Clopenthixolum
Clopentixol
Clopixol
Clopixol (TN)
Zuclopenthixol
Zuclopenthixol (INN)
Zuclopenthixol [BAN:INN]
Zuclopenthixolum
Zuclopenthixolum [Latin]
Zuclopentixol
Zuclopentixol [Spanish]
    Show/Hide
Structure
Formula
C22H25ClN2OS
Molecular Weight
400.975
Canonical SMILES
OCCN1CCN(CC\C=C2\c3ccccc3Sc3ccc(Cl)cc23)CC1
    Show/Hide
InChI
InChI=1S/C22H25ClN2OS/c23-17-7-8-22-20(16-17)18(19-4-1-2-6-21(19)27-22)5-3-9-24-10-12-25(13-11-24)14-15-26/h1-2,4-8,16,26H,3,9-15H2/b18-5-
    Show/Hide
InChIKey
WFPIAZLQTJBIFN-DVZOWYKESA-N
CAS
53772-83-1
Physicochemical Property
logP
4.2363
Rotatable Bonds
5
Heavy Atom Count
27
Polar Areas
26.71
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
27

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 5311507
SID: 14928248
ChEMBL ID
CHEMBL53904
DrugBank ID
DB01624
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01354, 5-hydroxytryptamine receptor 6
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 169 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( Zuclopenthixol )
Drug Name Zuclopenthixol
Company Lundbeck pharmaceutical company
Indication
Schizophrenia
Approved
Target(s)
Dopamine D2 receptor (D2R)
Antagonist